GSK offers discount to win UK green light for platelet drug LONDON (Reuters) - GlaxoSmithKline has finally won a green light from Britain's healthcare cost agency NICE for its platelet-boosting drug Revolade, after offering a price discount to the country's state-run healthcare service. Revolade, also known as eltrombopag, was originally rejected in 2010 by the National Institute for Health and Clinical Excellence (NICE) as not cost-effective. Draft ...
June 12, 2013 - Reuters via Yahoo! News
Blood TherapyHas Patients Flocking to Washington DC's Pioneering Pain Doctor WASHINGTON, June 11, 2013 /PRNewswire/ -- Platelet-Rich Plasma (PRP) is a little-known treatment discovered by the athletic elite in 2009. A radical treatment for sports related and other chronic injuries, ...
June 11, 2013 - PR Newswire via Yahoo! Finance
Michael Cronin in Earthtimes Dr. Michael Cronin says, "During a Platelet therapy procedure the patient's blood is drawn and put into a centrifuge which separates the plasma containing the essential platelets from the unneeded red blood cells. The PRP solution is carefully...
Leila Shahid in Sydney Morning Herald These findings underscore the potential of DG041 as a next-generation oral anti-platelet: a compound that can reduce the risk of thrombi formation without increasing overall bleeding risk. While the current standard of care, clopidogrel and... Kari Stefansson http://www.google.com/url?q=http://en.wikipedia.org/wiki/K%C3%A1ri_Stef%C3%A1nsson&source=dictionary&usg=AFQjCNE4zlrENEs81XVNitp9yN9A9qxqlQ CNNMoney.com (press release) http://www.google.com/url?q=http://money.cnn.com/news/newsfeeds/articles/prnewswire/200806300819PR_NEWS_USPR_____NYM056.htm&source=dictionary&usg=AFQjCNFXak-78NAN-G6_HZy1S-S7EQdbQg Jun 30, 2008
75090 101316 platelet Initial tests confirmed the abnormal blood count, high white blood cell count and low platelet count and ruled out a diagnosis of leukaemia", Palestinian envoy to Paris Leila Shahid said in the first joint statement with the Percy military...